Log In
BCIQ
Print this Print this
 

oxycodone (Egalet-002) (formerly EG-P114)

  Manage Alerts
Collapse Summary General Information
Company Egalet Corp.
DescriptionAbuse-deterrent, extended-release, oral formulation of oxycodone
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation U.S. - Fast Track (Treat moderate to severe pain)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today